enGene Therapeutics Inc. (ENGN): SCHEDULE 13G/A filed Feb 14, 2025

Form type

SCHEDULE 13G/A

Filing date

Feb 14, 2025

Accession number

0001104659-25-013919

Filer

enGene Therapeutics Inc. (CIK 1980845)